Clinical Trials List
2022-01-05 - 2026-01-06
Phase I/II
Recruiting3
Terminated1
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chia-Chi Lin Division of Hematology & Oncology
- HUAI-CHENG HUANG Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Yu-Chieh Tsai Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- 連銘瑜 Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- TSU-YI CHAO 無
- 莊博雅 無
- Yao-Yu Hsieh 無
- HUI-WEN LIU 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
382 participants
